Jones Day, Wilmer advise on $640m Celgene-Gloucester deal

Jones Day and Wilmer Cutler Pickering Hale & Dorr are handling the planned acquisition of Gloucester Pharmaceuticals Inc. by biotech company Celgene Corporation, a deal worth up to $640 million.

Jones Day, Wilmer advise on $640m Celgene-Gloucester deal amlawdaily.typepad.com Tue, Dec 8, 2009